iOS CamAPS FX
by CamDiab
510(k) K261896
iOS CamAPS FX is a Class II device made by CamDiab, cleared under FDA 510(k) K261896 on 16 Sep 2026, active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK261896 | Date16 Sep 2026 | StatusActive |
Official records
- FDA 510(k) database K261896
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- QJI
- Device class
- Class II
- Regulation
- 21 CFR Part 862.1356
- Advisory committee
- Clinical Chemistry
- FDA decision
- SESE Substantially Equivalent
Similar devices
Other devices filed under FDA product code QJI (Interoperable Automated Glycemic Controller).
- iLet® Dosing Decision Software by Beta Bionics, Inc.
- Control-IQ Technology by Tandem Diabetes Care, Inc.
- Tidepool Loop by Tidepool Project
- Omnipod 6 algorithm by Insulet Corporation
- SmartGuard Technology by MEDTRONIC MINIMED, INC.
- Control-IQ+ technology by Tandem Diabetes Care, Inc.
- SmartGuard technology; Predictive Low Glucose technology by MEDTRONIC MINIMED, INC.
- SmartAdjust™ Technology by Insulet Corporation
- twiist Loop Algorithm by Deka Research and Development
- DBLG2 by Diabeloop